Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke
Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the effect of Dextro-amphetamin added to physiotherapy on
motor recovery in patients after stroke. The study is a double-blinded placebo-controlled
randomised controlled trial.
Patients after a first-ever ischemic stroke will receive Dexamphetamine (10mg) twice per week
for a duration of five weeks after a baseline phase of two weeks.
The outcome measure focuses on motor recovery and will be assessed:
- one and two weeks before study intervention (baseline phase)
- five times during the study intervention
- one week after study intervention (follow-up)
- once after six and twelve months after start of the study intervention (follow-up).